Posts

Showing posts from September, 2020

Shionogi Announces FDA Approval of FETROJA® (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia - Odessa American

Shionogi Announces FDA Approval of FETROJA® (cefiderocol) for the Treatment of Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia    Odessa American
Post a Comment
Read more

Brazil Approves RedHill Biopharma's Phase 2/3 COVID-19 Study with Opaganib - BioSpace

Brazil Approves RedHill Biopharma's Phase 2/3 COVID-19 Study with Opaganib    BioSpace
Post a Comment
Read more

Veeva Systems (VEEV), Bioforum Report Collaboration with RedHill Biopharma (RDHL) o Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data - StreetInsider.com

Veeva Systems (VEEV), Bioforum Report Collaboration with RedHill Biopharma (RDHL) o Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data    StreetInsider.com
Post a Comment
Read more

Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data - BioSpace

Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data    BioSpace
Post a Comment
Read more

Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data - BioSpace

Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data    BioSpace
Post a Comment
Read more

Brazil Approves RedHill Biopharma's Phase 2/3 COVID-19 Study with Opaganib - StreetInsider.com

Brazil Approves RedHill Biopharma's Phase 2/3 COVID-19 Study with Opaganib    StreetInsider.com
Post a Comment
Read more

Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID‐19 (SARS‐CoV‐2) - wiley.com

Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID‐19 (SARS‐CoV‐2)    wiley.com
Post a Comment
Read more

Top in ID: COVID-19 vaccine, antimicrobial-resistant infections - Healio

Top in ID: COVID-19 vaccine, antimicrobial-resistant infections    Healio
Post a Comment
Read more

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L - PharmiWeb.com

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L    PharmiWeb.com
Post a Comment
Read more

Shionogi launches Fetcroja in the UK - The Pharma Letter

Shionogi launches Fetcroja in the UK    The Pharma Letter
Post a Comment
Read more

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L - PharmiWeb.com

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L    PharmiWeb.com
Post a Comment
Read more

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L - PharmiWeb.com

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L    PharmiWeb.com
Post a Comment
Read more

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L - PharmiWeb.com

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L    PharmiWeb.com
Post a Comment
Read more

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L - PharmiWeb.com

SHIONOGI LAUNCHES FETCROJA® (CEFIDEROCOL) IN THE UNITED KINGDOM FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH L    PharmiWeb.com
Post a Comment
Read more

Shionogi launches Fetcroja in the UK - The Pharma Letter

Shionogi launches Fetcroja in the UK    The Pharma Letter
Post a Comment
Read more

Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation - nejm.org

Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation    nejm.org
Post a Comment
Read more

Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation - nejm.org

Case 29-2020: A 66-Year-Old Man with Fever and Shortness of Breath after Liver Transplantation    nejm.org
Post a Comment
Read more

Entasis Therapeutics to Participate in Upcoming Healthcare Investor Conferences - GlobeNewswire

Entasis Therapeutics to Participate in Upcoming Healthcare Investor Conferences    GlobeNewswire
Post a Comment
Read more

Gram-Negative Bacterial Infection Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025 - The Market Correspondent

Gram-Negative Bacterial Infection Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025    The Market Correspondent
Post a Comment
Read more

Gram-Negative Bacterial Infection Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025 - The Market Correspondent

Gram-Negative Bacterial Infection Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025    The Market Correspondent
Post a Comment
Read more

Clinical and microbiological monitoring of Cystic Fibrosis patients, three years of follow-up via Tele-Medicine: an empirical research - DocWire News

Clinical and microbiological monitoring of Cystic Fibrosis patients, three years of follow-up via Tele-Medicine: an empirical research    DocWire News
Post a Comment
Read more

Changes in the Colour of Urine: What it Could Mean and When to Seek Help - News18

Changes in the Colour of Urine: What it Could Mean and When to Seek Help    News18
Post a Comment
Read more

Gram-Negative Bacterial Infection Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025 - The Market Correspondent

Gram-Negative Bacterial Infection Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025    The Market Correspondent
Post a Comment
Read more

Beyond antibiotics: harnessing bacteria's natural predators | Feature - The Pharmaceutical Journal

Beyond antibiotics: harnessing bacteria's natural predators | Feature    The Pharmaceutical Journal
Post a Comment
Read more

Stewardship / Resistance Scan for Sep 09, 2020 | CIDRAP - CIDRAP

Stewardship / Resistance Scan for Sep 09, 2020 | CIDRAP    CIDRAP
Post a Comment
Read more

Global $12.8 Billion Antimicrobial Textile Markets, 2016-2018 & 2019-2025 - ResearchAndMarkets.com - ACROFAN USA

Global $12.8 Billion Antimicrobial Textile Markets, 2016-2018 & 2019-2025 - ResearchAndMarkets.com    ACROFAN USA
Post a Comment
Read more

Could Antibiotics Make Breast Milk Less Healthy for Babies? - HealthDay News

Could Antibiotics Make Breast Milk Less Healthy for Babies?    HealthDay News
Post a Comment
Read more

Heuck's Lab Honored with NIH Small Business Technology Transfer Award - UMass News and Media Relations

Heuck's Lab Honored with NIH Small Business Technology Transfer Award    UMass News and Media Relations
Post a Comment
Read more

IDSA issues guidance on treatment of drug-resistant pathogens - Homeland Preparedness News

IDSA issues guidance on treatment of drug-resistant pathogens    Homeland Preparedness News
Post a Comment
Read more

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference - Yahoo Finance

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference    Yahoo Finance
Post a Comment
Read more

Hospital Acquired Infections Treatment Market Global Analysis, Segmentation, Demand, Share, Size, Growth, Trends, Demand Forecast to 2027 - The Daily Chronicle

Hospital Acquired Infections Treatment Market Global Analysis, Segmentation, Demand, Share, Size, Growth, Trends, Demand Forecast to 2027    The Daily Chronicle
Post a Comment
Read more

IDSA issues new guidance for antimicrobial-resistant infections - Healio

IDSA issues new guidance for antimicrobial-resistant infections    Healio
Post a Comment
Read more

Trained Innate Immunity, Epigenetics, and Covid-19 | NEJM - nejm.org

Trained Innate Immunity, Epigenetics, and Covid-19 | NEJM    nejm.org
Post a Comment
Read more

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference - Yahoo Finance

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference    Yahoo Finance
Post a Comment
Read more

Heuck's Lab Honored with NIH Small Business Technology Transfer Award - UMass News and Media Relations

Heuck's Lab Honored with NIH Small Business Technology Transfer Award    UMass News and Media Relations
Post a Comment
Read more

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501 - BioSpace

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501    BioSpace
Post a Comment
Read more

RedHill Biopharma's Opaganib Demonstrates Complete Inhibition of SARS-CoV-2 - BioSpace

RedHill Biopharma's Opaganib Demonstrates Complete Inhibition of SARS-CoV-2    BioSpace
Post a Comment
Read more

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501 - BioSpace

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501    BioSpace
Post a Comment
Read more

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference - Stockhouse

ContraFect to Present at the 2020 Cantor Global Virtual Healthcare Conference    Stockhouse
Post a Comment
Read more

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501 - PRNewswire

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501    PRNewswire
Post a Comment
Read more

Aridis Pharmaceuticals to Present at Upcoming Investor Conferences - WFMZ Allentown

Aridis Pharmaceuticals to Present at Upcoming Investor Conferences    WFMZ Allentown
Post a Comment
Read more

BioAegis Therapeutics Announces Study Indicating Gelsolin Treatment Improves Survival and Reduces Lung Injury in Antibiotic Resistant Pneumonia - BioSpace

BioAegis Therapeutics Announces Study Indicating Gelsolin Treatment Improves Survival and Reduces Lung Injury in Antibiotic Resistant Pneumonia    BioSpace
Post a Comment
Read more

RedHill Biopharma's Opaganib Demonstrates Complete Inhibition of SARS-CoV-2 - BioSpace

RedHill Biopharma's Opaganib Demonstrates Complete Inhibition of SARS-CoV-2    BioSpace
Post a Comment
Read more

Researchers receive $1.9 million federal grant to find Lyme disease vaccine - News-Medical.Net

Researchers receive $1.9 million federal grant to find Lyme disease vaccine    News-Medical.Net
Post a Comment
Read more

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501 - thepress.net

Aridis Announces Agreement with the FDA on Updated Phase 2 Clinical Trial Design for AR-501    thepress.net
Post a Comment
Read more

SCHUTZEN Chemical Group launches SCHUTZEN WEAR SAFE Fabric Softener and Laundry Sanitiser - India Education Diary

SCHUTZEN Chemical Group launches SCHUTZEN WEAR SAFE Fabric Softener and Laundry Sanitiser    India Education Diary
Post a Comment
Read more

Technologies for Removal of Microbiological Contaminants in Drinking Water - Water Quality Products

Technologies for Removal of Microbiological Contaminants in Drinking Water    Water Quality Products
Post a Comment
Read more

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals - The Lancet

Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals    The Lancet
Post a Comment
Read more

Polyphor announces financial results for the first half 2020 - PharmiWeb.com

Polyphor announces financial results for the first half 2020    PharmiWeb.com
Post a Comment
Read more

Technologies for Removal of Microbiological Contaminants in Drinking Water - Water Quality Products

Technologies for Removal of Microbiological Contaminants in Drinking Water    Water Quality Products
Post a Comment
Read more

Checklist for infection control in the emergency department - Wiley

Checklist for infection control in the emergency department    Wiley
Post a Comment
Read more

Checklist for infection control in the emergency department - Wiley

Checklist for infection control in the emergency department    Wiley
Post a Comment
Read more

Wearable, portable invention offers options for treating antibiotic-resistant infections, wounds - Purdue News Service

Wearable, portable invention offers options for treating antibiotic-resistant infections, wounds    Purdue News Service
Post a Comment
Read more

Covid-19: Antibodies found in 8 per cent people in Haryana - ETHealthworld.com

Covid-19: Antibodies found in 8 per cent people in Haryana    ETHealthworld.com
Post a Comment
Read more

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS - StreetInsider.com

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS    StreetInsider.com
Post a Comment
Read more

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS - Galveston County Daily News

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS    Galveston County Daily News
Post a Comment
Read more

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS - StreetInsider.com

Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS    StreetInsider.com
Post a Comment
Read more

Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumon - StreetInsider.com

Key Publication of Clinical Study Demonstrates Unyvero Lower Respiratory Tract (LRT) Panel is Likely to Alter Antibiotic Management of Significant Numbers of Patients Presenting with Suspected Pneumon    StreetInsider.com
Post a Comment
Read more

CIT's Virginia Founders Fund Invests in Techulon to Advance the Development of Targeted Antibiotics - GlobeNewswire

CIT's Virginia Founders Fund Invests in Techulon to Advance the Development of Targeted Antibiotics    GlobeNewswire
Post a Comment
Read more

This 'Slowly Evolving Crisis' Needs Attention - Medscape

This 'Slowly Evolving Crisis' Needs Attention    Medscape
Post a Comment
Read more

CIT's Virginia Founders Fund Invests in Techulon to Advance the Development of Targeted Antibiotics - GlobeNewswire

CIT's Virginia Founders Fund Invests in Techulon to Advance the Development of Targeted Antibiotics    GlobeNewswire
Post a Comment
Read more